FDA.reportPublic FDA data

FDA label 28f7f321-29f9-4a2e-a21f-6d2420eb755c

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
58123f25-56d8-4b29-83fd-ca4981a38c08
SPL ID
28f7f321-29f9-4a2e-a21f-6d2420eb755c
Version
1
Effective date
2011-03-30
Source export date
2026-10-12
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:47:50

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 2 matching rows.

warnings

Warnings Ask a doctor before use if you are taking minocycline, doxycycline, tetracycline or are on coumadin therapy, zinc treatment may inhibit the absorption of these medicines Stop use and ask your healthcare practitioner if symptoms persist beyond 7 days. COLD-EEZE® Lozenges are formulated to reduce the duration of common cold symptoms and may be insufficient treatment for Influenza or Allergies. Diabetic Warning: sugar replacements may affect blood sugar levels. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

warnings

Diabetic Warning: sugar replacements may affect blood sugar levels.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.